Nautilus Biotechnology, Inc.
Datakwaliteit: 83%
NAUT
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
€ 3,21
▲
€ 0,08
(2,56%)
Marktkapitalisatie: 406,27 M
Prijs
€ 3,21
Marktkapitalisatie
406,27 M
Dagbereik
€ 3,10 — € 3,27
52-Weeksbereik
€ 0,62 — € 4,31
Volume
145.164
Openen € 3,12
50D / 200D Gem.
€ 2,63
22,03% above
50D / 200D Gem.
€ 1,59
102,06% above
Quick Summary
Belangrijkste Punten
Negative free cash flow of -51,97 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-33,69%
Boven sectorgemiddelde (-53,41%)
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio14,95
Interest CoverageN/A
Waardering
PE (TTM)
-6,89
Onder sectorgemiddelde (-1,48)
P/B Ratio2,40
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,9 | -1,5 |
| P/B | 2,4 | 1,6 |
| ROE % | -33,7 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -59,00 M |
| ROE | -33,69% | ROA | -28,50% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -51,97 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 14,95 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 125,34 M | Tangible Book Value | 169,14 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6,89 | Forward P/E | N/A |
| P/B Ratio | 2,40 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -12,79% | ||
| Market Cap | 406,27 M | Enterprise Value | 382,40 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,47 | Revenue / Share | N/A |
| FCF / Share | -0,41 | OCF / Share | -0,40 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 88,09% |
| SBC-Adj. FCF | -60,53 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -59,00 M | -70,78 M | -63,68 M | -57,92 M | -523.083,0 |
| EPS (Diluted) | -0,47 | -0,56 | -0,51 | -0,46 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | -576.035,0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 41,11 M | 50,48 M | 47,25 M | 37,67 M | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 191,11 M | 242,74 M | 305,57 M | 350,05 M | 150,86 M |
| Total Liabilities | 34,14 M | 34,01 M | 40,21 M | 35,13 M | 5,62 M |
| Shareholders' Equity | 156,97 M | 208,73 M | 265,35 M | 314,92 M | 5,00 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 12,39 M | 27,65 M | 19,40 M | 114,52 M | — |
| Current Assets | 105,96 M | 132,83 M | 176,84 M | 187,21 M | 1,30 M |
| Current Liabilities | 7,95 M | 7,63 M | 9,12 M | 6,79 M | 388.507,0 |
{"event":"ticker_viewed","properties":{"ticker":"NAUT","listing_kind":"stock","pathname":"/stocks/naut","exchange":"Nasdaq","country":"US"}}